Lake Street Capital Markets Downgrades Cardiovascular Systems (CSII) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Abbott (ABT) acquires Cardiovascular Systems (CSII) in 'brilliant move'
February 9, 2023 11:12 AM EST(Updated - February 9, 2023 11:27 AM EST)
UPDATE: Updated to include analyst comments.
Abbott (NYSE: ABT) announced today that the medical device company has entered into a definitive agreement to acquire Cardiovascular Systems, Inc. (NASDAQ: CSII). Under terms of the agreement, CSII stockholders will receive $20 per common share at a total expected equity value of approximately $890... More



